Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency.

AUTOR(ES)

Heyman, R A

RESUMO

The cell-specific expression of herpes simplex virus 1 thymidine kinase (HSV-1-tk) has provided a simple and highly efficient technique to achieve conditional ablation of targeted cell types in transgenic mice. The ablation is induced by treating transgenic animals expressing HSV-1-tk with the antiherpetic drug ganciclovir. In lymphoid tissues of mice expressing HSV-1-tk from an immunoglobulin promoter, administration of ganciclovir leads to massive destruction of B- and T-cell lineages. Tissues not expressing HSV-1-tk are insensitive to drug treatment. After depletion of greater than 99% of total thymocytes, a number of progenitor cells remain that are able to repopulate all T-cell lineages within 7 days. The ability to control and direct ablation allows for creation of conditional mutant phenotypes at precise periods of development. This technique also provides a potential means to enrich stem cell populations as well as permitting the creation of animal models for particular pathological conditions.

Documentos Relacionados

• Microflora analysis of a child with severe combined immune deficiency.
• Animal model for immune dysfunction associated with adenosine deaminase deficiency.
• Fetal anaemia due to pyruvate kinase deficiency.
• A monomeric form of pyruvate kinase in human pyruvate kinase deficiency.
• Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency.